CASE Op-Ed – RealClear Markets: Beware Efforts In the House to ‘Fix’ Freight Railroads
August 10, 2022 A key pillar of the deceptively named “Inflation Reduction Act” is furthering the climate agenda of...
CASE Op-Ed – Townhall: Rail Regulators Are Choosing Political Allies Over U.S. Consumers
April 6, 2022 A little-known federal agency is hatching big plans that could impact millions of consumers across the...
CASE Op-Ed – RealClear Markets: This Is the Wrong Time, and the Wrong Place for Amtrak’s Gulf Coast Push .
March 29, 2022 In the midst of once-in-a-generation levels of inflation, record-high gas prices, and a lingering supply chain...
CASE Op-Ed – Provo Daily Herald (Utah): Railroads in Utah and Beyond Under Threat from Biden Admin
December 15, 2021 Senator Mike Lee, R-Utah, continues to be a leader in fighting for quality professionals to lead...
CASE Op-Ed – Issues & Insights: Time To Change Freight Rules That Add Barriers To The U.S. Recovery
Gerard Scimeca – Chairman, CASE October 21, 2020 U.S. regulatory body is taking aim at one of the most vital...
CASE Op-Ed – Morning Consult: An Agency in the Trump Era Bucks the Deregulation Trend
Matthew Kandrach – CASE President July 10, 2019 he Trump administration continues to deregulate in sensible ways across the government, unshackling...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/